Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06587100 · ClinicalTrials.gov registry record
Wearable Activity Tracking to Curb Hospitalizations
A clinical trial of Malignant Solid Neoplasm and Hematopoietic Neoplasm, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- 260
- Enrollment target
- 1
- Study location
NCT06587100: Recruiting study of Malignant Solid Neoplasm and Hematopoietic Neoplasm, sponsored by University of California, San Francisco.
NCT06587100 is a study of Malignant Solid Neoplasm and Hematopoietic Neoplasm that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 260 participants, below the 1,139-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06587100, a study of Malignant Solid Neoplasm and Hematopoietic Neoplasm, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- 260 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being done to collect patient generated health data to predict the risk of patients needing emergency department visits or hospitalization before, during. and after receiving radiation therapy.
Primary Outcome
The AUC-ROC of the step count model will measure the performance of a classification model by plotting the rate of true positives against false positives, and the score ranges from 0 - 1. The higher the AUC, the better the model's performance at distinguishing between the positive and negative classes. The AUC-ROC will be reported including both estimates and confidence intervals. All models will be reported per up-to-date guidelines, such as Minimum Information about Clinical Artificial Intelli
Conditions Studied
Interventions
- DEVICE Fitbit
- DEVICE Apple HealthKit-based devices
Study Locations (1)
California
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2025-04-07 |
| Est. Completion | 2027-12-31 |
What NCT06587100 shows while recruiting
NCT06587100 is an observational study that tracks outcomes without assigning an intervention. The registered 260 participants enrollment target is mid-sized for trials with a published cap, below the 1,139-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (77% lower).
The record links to 3 conditions, with Malignant Solid Neoplasm appearing as the primary indexed condition, and to 2 interventions - of which Fitbit is the first listed.
NCT06587100 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06587100 about?
NCT06587100 is a clinical study titled "Wearable Activity Tracking to Curb Hospitalizations". This study is being done to collect patient generated health data to predict the risk of patients needing emergency department visits or hospitalization before, during. and after receiving radiation therapy.
What is the current status of trial NCT06587100?
This trial is currently recruiting. The enrollment target is 260 participants. The study started on 2025-04-07. Estimated completion is 2027-12-31.
What conditions does trial NCT06587100 study?
This clinical trial studies the following conditions: Malignant Solid Neoplasm, Hematopoietic Neoplasm, Lymphatic System Neoplasm.
What interventions are being tested in trial NCT06587100?
The interventions under investigation include: Fitbit (DEVICE), Apple HealthKit-based devices (DEVICE).
Who is sponsoring clinical trial NCT06587100?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06587100 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Solid Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06587100's enrollment target sits among peer trials
260 52nd of 176 higher than 125 of 176 other Malignant Solid Neoplasm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Malignant Solid Neoplasm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of Early Identification of Cognitive Side Effects of Immunotherapy
RECRUITING
-
Investigating Memory and Physical Activity After Cancer Treatment in Survivors of Adolescent and Young Adult Cancers
RECRUITING
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
-
Exercise Program (TEAM Me) for the Improvement of Movement and Mobility in Pediatric and Adolescent and Young Adult Patients With Cancer Undergoing a Blood Stem Cell Transplant
RECRUITING · NA
-
Voices: Messages of Wisdom and Hope in the Face of Illness
RECRUITING
-
Collection and Storage of Tissue and Blood Samples From Patients With Cancer
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02283996 · 260 participants · Phase 4
Adhesive Capsulitis: Prospective Analysis of Efficacy and Financial Impact for Use of Physical Therapy in Treatment
- NCT03276793 · 260 participants · NA
Brain Connectivity in Depression
- NCT03407469 · 260 participants
Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization
- NCT03713125 · 260 participants · NA
Executive Function in Early Childhood
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI